These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 5255682

  • 41. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A, Smakowska E, Waszkiewicz L, Błaczkowska A, Kin-Dittmann I, Zielińska K, Czajkowska B, Pajsert E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [Abstract] [Full Text] [Related]

  • 42. [Letter: Comparative study of busulfan and of the combination of busulfan with splenic radiotherapy in the treatment of chronic myeloid leukemias].
    Messerschmitt J, Colonna P, Hamladji RM, Belkhodja A, Taleb A.
    Nouv Presse Med; 1975 Nov 15; 4(39):2812. PubMed ID: 1105426
    [No Abstract] [Full Text] [Related]

  • 43. Management of busulphan non-responsive chronic myeloid leukaemia.
    Roul RK, Singh AD.
    J Indian Med Assoc; 1982 Aug 01; 79(3):27-9. PubMed ID: 6960081
    [No Abstract] [Full Text] [Related]

  • 44. [Chronic myelogenous leukemia. Results of therapy with busulfan].
    Olesen J, Videbaek A.
    Nord Med; 1969 Oct 09; 82(41):1284-90. PubMed ID: 5260856
    [No Abstract] [Full Text] [Related]

  • 45. BCG immunotherapy in chronic myelocytic leukaemia.
    Kardaszewicz E, Siejeńska L.
    J Hyg Epidemiol Microbiol Immunol; 1976 Oct 09; 20(1):32-5. PubMed ID: 1063221
    [No Abstract] [Full Text] [Related]

  • 46. [Regularities in the change in leukocyte count during treatment of chronic myeloid leukosis].
    Emanuél' NM, Sherman SI, Levitin EI, Rozanova LM, Evseenko LS, Kukharenko IuA.
    Dokl Akad Nauk SSSR; 1967 Aug 11; 175(5):1197-200. PubMed ID: 5270825
    [No Abstract] [Full Text] [Related]

  • 47. [Therapy of chronic myeloid leukemia].
    Mey U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Aug 11; 108(2):268-74. PubMed ID: 6168538
    [No Abstract] [Full Text] [Related]

  • 48. Busulfan in early pregnancy.
    Williams DW.
    Obstet Gynecol; 1966 May 11; 27(5):738-40. PubMed ID: 5220059
    [No Abstract] [Full Text] [Related]

  • 49. Prolonged busulfan-induced remissions in chronic myeloid leukemia.
    Benjamin D, Djaldetti M, Mammon Z, Shaklai M, Pinkhas J.
    Acta Haematol; 1979 May 11; 62(2):119-20. PubMed ID: 119401
    [Abstract] [Full Text] [Related]

  • 50. [Survival in chronic myeloid leukemia following aplasia caused by Misulban].
    Perreau P, Gardais J.
    Sem Hop; 1969 Mar 26; 45(15):964-70. PubMed ID: 4307171
    [No Abstract] [Full Text] [Related]

  • 51. [A study of thrombopoiesis in chronic leucosis in connection with different methods of treatment].
    Pogosian AS, Eliian LN, Aĭdinian DS, Bleian GT.
    Zh Eksp Klin Med; 1969 Mar 26; 9(5):86-90. PubMed ID: 5269261
    [No Abstract] [Full Text] [Related]

  • 52. [Ambulatory treatment of patients with chronic myeloid leukemia].
    Lobanova NA.
    Ter Arkh; 1981 Mar 26; 53(9):25-8. PubMed ID: 6946602
    [No Abstract] [Full Text] [Related]

  • 53. Chronic myelocytic leukemia: treatment and biology.
    Preisler HD, Higby DJ.
    N Y State J Med; 1982 Apr 26; 82(5):703-10. PubMed ID: 7043332
    [No Abstract] [Full Text] [Related]

  • 54. Estimation of chronic phase duration in Ph-positive chronic myelocytic leukemia treated with busulfan: statistical analysis on Japanese patients.
    Hashimoto T, Ohtaki M, Ueoka H, Munaka M, Kuramoto A, Kamada N.
    Int J Hematol; 1994 Jul 26; 60(1):59-69. PubMed ID: 7919239
    [Abstract] [Full Text] [Related]

  • 55. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
    Lamas S, Sanjuán I, Zabala P, Millán I, Cabrera R, Barbolla L, Menéndez J, Fernández MN.
    Sangre (Barc); 1982 Jul 26; 27(4A):493-507. PubMed ID: 6961564
    [No Abstract] [Full Text] [Related]

  • 56. Hydroxyurea therapy in chronic myeloid leukemia.
    Agarwal MB, Mehta BC.
    J Assoc Physicians India; 1982 Jul 26; 30(7):427-8. PubMed ID: 6963266
    [No Abstract] [Full Text] [Related]

  • 57. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
    Japp H.
    Schweiz Med Wochenschr; 1974 Aug 10; 104(32):1115-9. PubMed ID: 4548568
    [No Abstract] [Full Text] [Related]

  • 58. [Busulfan-induced adrenal insufficiency].
    Rodríguez Cuartero A, Durán Cara E, Peláez Redondo J.
    Rev Clin Esp; 1973 Oct 15; 131(1):73-8. PubMed ID: 4520013
    [No Abstract] [Full Text] [Related]

  • 59. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
    Etcheberry R, Becker P, Delmastro J, Donoso S.
    Rev Med Chil; 1973 Jan 15; 101(1):42-6. PubMed ID: 4518637
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.